Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1351 of 6351
-
New vaccine aims to stop Virus-Linked cancers in organ transplant patients
Vaccine Recruiting nowThis phase 1B trial tests the safety, side effects and best dose of rh-Hsc70- BZLF1 peptide complex (OSU-2131) with Stimulon (Trademark) QS-21 and evaluates how well it works in preventing Epstein-Barr virus (EBV) infection and related cancers in healthy volunteers and patients a…
Phase 1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Vaccine
Last updated Jul 04, 2026 00:00 UTC
-
Could a diabetes and cholesterol drug combo regrow hair?
Disease control Not yet recruitingAlopecia areata (AA) is a chronic immune disease characterized by non-scarring hair loss of the scalp or other hair-bearing areas Patients with AA frequently report high levels of dissatisfaction with commonly used treatment options due to ineffectiveness and adverse effects. The…
Sponsor: Sohag University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Scientists map cellular secrets of recurring colon polyps to prevent future cancer
Knowledge-focused Not yet recruitingWe aim to establish a single-cell atlas of primary adenomas, recurrent adenomas, and paired normal mucosa, identify recurrence-associated cell subpopulations and transcriptional pathways, and construct a risk prediction model for recurrence (integrating multi-omics features and c…
Sponsor: Zhongshan Hospital Xiamen University • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Blood gas clues: could CO2 markers forecast heart trouble in young surgery patients?
Knowledge-focused Recruiting nowIn congenital cardiac intensive care, low cardiac output syndrome (LCOS) after surgery is defined by a decrease in cardiac output due to cardiac dysfunction. This syndrome is responsible for postoperative mortality and morbidity, as well as prolonged hospitalization. carbon diox…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Sep 10, 2026 04:00 UTC
-
Can a new protein drug shield kids with cancer from dangerous infections?
Disease control Recruiting nowQLC2519 (Mai Li Sheng®) is a new protein drug created by fusing the N-terminal of highly active modified G-CSF with the C-terminal of HSA. The modified G-CSF retained high activity while reducing affinity for the G-CSF receptor, which can significantly inhibit the the G-CSF recep…
Phase 2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a measles vaccine fight pancreatic cancer?
Disease control Recruiting nowBy doing this study, it is the hope to learn whether an injection of the measles, mumps, rubella (MMR) vaccine developed by Merck \& Co. (Merck's M-M-R® II) into the tumor is safe and effective in making the tumor smaller.
Phase 1/2 • Sponsor: University of Arkansas • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New antibody aims to neutralize allergies by clearing IgE
Disease control Recruiting nowThis is a Phase 1combined single ascending dose (SAD)/multiple ascending dose (MAD) randomized, double-blind, placebo-controlled trial to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of single and multiple ascending subcutaneous doses of…
Phase 1 • Sponsor: Lycia Therapeutics, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New triple inhaler aims to tame uncontrolled asthma
Disease control Recruiting nowThis is a study comparing CHF 5993 pMDI HFA-152a with CHF 1535 pMDI HFA-134a in Chinese patients with asthma uncontrolled on medium doses of ICS+LABA.
Phase 3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Second dose of experimental drug may help when first fails
Disease control Recruiting nowThis study is intended to explore the efficacy and safety of a second course of ianalumab after experiencing treatment failure in the pivotal Primary Immune Thrombocytopenia (ITP) trials (CVAY736I12301, CVAY736Q12301) and after loss of durable response in the pivotal Warm Autoimm…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for thalassemia patients: drug may cut blood transfusions
Disease control Recruiting nowThe purpose of this study is to evaluate luspatercept treatment in adults with transfusion-dependent beta-Thalassemia in the Middle East
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Gene therapy injection aims to save sight in rare genetic disease
Disease control Recruiting nowThe goal of this first in human study is to evaluate the preliminary safety and tolerability of AXV-101 in participants with BBS1. The main questions it aims to answer are: * Is AXV-101 safe and tolerable to use in participants with BBS1? * To determine the therapeutic dose of A…
Early phase 1 • Sponsor: Axovia Therapeutics • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Mapping Cancer's next move: study tracks where prostate cancer returns after aggressive radiotherapy
Knowledge-focused Recruiting nowThis is an ambispective, multicenter, observational real-world registry of patients with synchronous de novo oligometastatic prostate cancer, defined as prostate cancer with up to 10 extraregional metastatic lesions diagnosed at initial presentation or within 6 months of the prim…
Sponsor: Affidea Nu-med Center of Oncological DIagnostics and Therapy • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Ear-Clip nerve zaps may wake hidden awareness after brain injury
Symptom relief Recruiting nowSome patients with severe traumatic brain injury cannot respond at the bedside, yet about 1 in 4 may be aware but unable to show it - a hidden state called cognitive motor dissociation. This study tests a gentle, non-invasive treatment delivered through clips on the left ear that…
Sponsor: Sima Mofakham • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Can a better vitamin mix beat iron pills for anemia in pregnancy?
Disease control Not yet recruitingThis study aims to compare the effectiveness of Multiple Micronutrient Supplementation (MMS), Iron-Folic Acid (IFA) supplementation, and combined MMS+IFA supplementation among pregnant women. Maternal anemia and micronutrient deficiencies are common during pregnancy and can adver…
Sponsor: Sindh Institute of Child Health and Neonatology • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can immune markers predict breast cancer treatment success?
Knowledge-focused Recruiting nowThe goal of this clinical trial is to identify cellular and molecular determinants of response to neoadjuvant immunochemotherapy in women aged 18 or older with early-stage triple-negative breast cancer (TNBC). The main questions it aims to answer are: * Can detailed immune profi…
Sponsor: Center Eugene Marquis • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
New pill could ease osteoarthritis knee pain without surgery
Symptom relief Recruiting nowThe main purpose of this study is to test the safety and efficacy of study drug for the treatment of knee pain due to osteoarthritis (OA). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new tr…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Could LVAD patients ditch aspirin? new trial aims to find out
Disease control Not yet recruitingThis multi-center, prospective, randomized, double-blinded, placebo-controlled study aims to investigate whether withdrawal of aspirin from the antithrombotic regimen in patients supported with the CH-VAD pump is non-inferior to the standard antithrombotic regimen of vitamin K an…
Phase 4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New DNA vaccine aims to clear Cancer-Causing HPV
Disease control Recruiting nowThis research is being done to test the safety and feasibility of an investigational DNA vaccine called pBI-11 and to find out what effects, if any, it has on women with persistent human papillomavirus 16 (HPV16+) and/or human papillomavirus (HPV18+) cervical infection. The DNA …
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a whisper in your ear treat sleep apnea?
Disease control Recruiting nowPatients with obstructive sleep apnea (OSA) often experience more frequent and severe breathing disturbances when sleeping in the supine (back-sleeping) position compared with non-supine positions. Positional therapy aims to reduce time spent sleeping in the supine position, but …
Sponsor: SleepDev, Inc • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can ultrasound predict difficult IV insertions before they happen?
Knowledge-focused CompletedUltrasound-guided internal jugular vein (IJV) catheterization is widely used in critically ill patients. Despite ultrasound guidance, difficult catheterization and first-pass failure remain clinically important and may increase the risk of mechanical complications. Pre-procedural…
Sponsor: Antalya Health Sciences University • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC